Nimesulide in the treatment of pelvic inflammatory diseases. A multicentre clinical trial conducted in Campania and Sicily

Drugs · 1993 · vol. 46(Supplement 1) , pp. 134–136 · doi:10.2165/00003495-199300461-00029 · PMID:7506152 · W1969564774
Non-randomised trial OA: closed CC0 ⤵ 1 in-corpus citation
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-08-01 ⓘ

This multicenter study assessed nimesulide's efficacy and tolerability in 400 patients with various gynecological inflammatory diseases, finding significant symptom improvement and good tolerability across all conditions.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

400 patients aged 18 to 71 years took part in a multicentre noncomparative study designed to assess the clinical efficacy and tolerability of nimesulide in gynaecological inflammatory disease: adnexitis (72 patients), cervicitis (78 patients), endometritis (18 patients), myometritis (22 patients), and combined disorders (210 patients). All patients were treated with nimesulide 100mg twice daily in granular form for an average of 19.5 days. The treatment produced good results in all types of diseases considered, with a significant decrease in severity of symptoms being observed. The drug was well tolerated.

My notes (saved in your browser only)

MeSH descriptors

Anti-Inflammatory Agents, Non-Steroidal Pelvic Inflammatory Disease Sulfonamides Adolescent Adult Aged Anti-Inflammatory Agents, Non-Steroidal Female Humans Middle Aged Pelvic Inflammatory Disease Sulfonamides Sulfonamides

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (2)

References (8)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:58:49.153990+00:00
License: CC0 · commercial use OK